alnylam
The Senior Manager / Regulatory Affairs will lead the development and execution of Japan regulatory strategies for assigned programs, ensuring alignment with global objectives and local requirements. They will manage regulatory submissions, health authority interactions, and collaborate with cross‑functional teams to support clinical development and product commercialization.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2002
Alnylam is a biopharmaceutical company that has pioneered RNA interference (RNAi) therapeutics, an innovative class of medicines that treats diseases by silencing the genes that cause or contribute to them. The company develops RNAi-based medicines targeting both rare and prevalent diseases across multiple therapeutic areas, with approved products and a robust investigational pipeline. Driven by science and inspired by patients, Alnylam is committed to delivering transformational medicines that address diseases at their genetic source.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for alnylam.
alnylam didn’t post a salary, so this is our estimate from similar listings.
3% above the average for this role
Senior Manager, Regulatory Affairs, Japan
Revolution Medicines
European Regulatory Affairs Lead
Amgen
Manager, Regulatory Affairs
sanofi us
Regulatory Affairs Manager, Japan
Revolution Medicines
Senior Manager Regulatory Strategy Oncology & Japan Affairs
Regeneron Pharmaceuticals
Regulatory Affairs Director
AstraZeneca